Industry NewsAbcam acquires gene-editing platform and oncology product portfolio from US biotech Applied StemCell
Product NewsAbcam and BrickBio announce partnership to incorporate conjugation-ready sites into antibodies
Industry NewsAbcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knockout Cell Lines and Lysates Portfolio
